Robert G. Holloway, M.D., M.P.H.

Robert G. Holloway, M.D., M.P.H.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 673
Rochester, NY 14642

Office: (585) 275-1200
Fax: (585) 244-2529
Administrative: (585) 273-3079

Journal Articles

Showing all 230 journal articles available.

2016 May 31
Robinson MT, Vickrey BG, Holloway RG, Chong K, Williams LS, Brook RH, Leng M, Parikh P, Zingmond DS. "The lack of documentation of preferences in a cohort of adults who died after ischemic stroke." Neurology. 2016 May 31; 86(22):2056-62. Epub 2016 Apr 08.
2016 May 4
Kim SY, De Vries R, Holloway RG, Kieburtz K. "Understanding the 'therapeutic misconception' from the research participant's perspective." Journal of medical ethics. 2016 May 4; Epub 2016 May 04.
2016 Mar 10
Kim SY, Wilson R, De Vries R, Ryan KA, Holloway RG, Kieburtz K. "Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?" Journal of medical ethics. 2016 Mar 10; Epub 2016 Mar 10.
2016 Feb
Creutzfeldt CJ, Robinson MT, Holloway RG. "Neurologists as primary palliative care providers: Communication and practice approaches." Neurology. Clinical practice. 2016 Feb; 6(1):40-48.
2015 Sep
Creutzfeldt CJ, Holloway RG, Curtis JR. "Palliative Care: A Core Competency for Stroke Neurologists." Stroke; a journal of cerebral circulation. 2015 Sep; 46(9):2714-9. Epub 2015 Aug 04.
2015 Aug
Creutzfeldt CJ, Engelberg RA, Healey L, Cheever CS, Becker KJ, Holloway RG, Curtis JR. "Palliative Care Needs in the Neuro-ICU." Critical care medicine. 2015 Aug; 43(8):1677-84.
2015 Aug
Kim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K. ""It is not guaranteed that you will benefit": True but misleading?" Clinical trials : journal of the Society for Clinical Trials. 2015 Aug; 12(4):424-9. Epub 2015 May 11.
2015 Aug
Cai X, Robinson J, Muehlschlegel S, White DB, Holloway RG, Sheth KN, Fraenkel L, Hwang DY. "Patient Preferences and Surrogate Decision Making in Neuroscience Intensive Care Units." Neurocritical care. 2015 Aug; 23(1):131-41.
2015 May
Kim SY, De Vries R, Parnami S, Wilson R, Kim HM, Frank S, Holloway RG, Kieburtz K. "Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?" Journal of medical ethics. 2015 May; 41(5):391-7. Epub 2014 May 22.
2015
Creutzfeldt CJ, Longstreth WT, Holloway RG. "Predicting decline and survival in severe acute brain injury: the fourth trajectory." BMJ : British medical journal. 2015 351:h3904. Epub 2015 Aug 06.
2015
Kim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K. "Could the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem?" IRB. 2015 37(4):11-8.
2014 Nov
Xian Y, Holloway RG, Smith EE, Schwamm LH, Reeves MJ, Bhatt DL, Schulte PJ, Cox M, Olson DM, Hernandez AF, Lytle BL, Anstrom KJ, Fonarow GC, Peterson ED. "Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage." Stroke; a journal of cerebral circulation. 2014 Nov; 45(11):3243-50. Epub 2014 Sep 11.
2014 Nov
Stroupe KT, Weaver FM, Cao L, Ippolito D, Barton BR, Burnett-Zeigler IE, Holloway RG, Vickrey BG, Simuni T, Follett KA. "Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites." Movement disorders : official journal of the Movement Disorder Society. 2014 Nov; 29(13):1666-74. Epub 2014 Sep 15.
2014 Sep 2
George BP, Kelly AG, Schneider EB, Holloway RG. "Current practices in feeding tube placement for US acute ischemic stroke inpatients." Neurology. 2014 Sep 2; 83(10):874-82. Epub 2014 Aug 06.
2014 Aug
Smith JK, Myers KP, Holloway RG, Landau ME. "Ethical considerations in elective amputation after traumatic peripheral nerve injuries." Neurology. Clinical practice. 2014 Aug; 4(4):280-286.
2014 Jun 12
Kelly AG, Holloway RG. "Hemicraniectomy for middle-cerebral-artery stroke." The New England journal of medicine. 2014 Jun 12; 370(24):2346-7.
2014 Jun
Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, Rabinstein AA, Saposnik G, Sheth KN, Zahuranec DB, Zipfel GJ, Zorowitz RD, . "Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association." Stroke; a journal of cerebral circulation. 2014 Jun; 45(6):1887-916. Epub 2014 Mar 27.
2014 Mar
Katzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW, , , , , , . "Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association." Stroke; a journal of cerebral circulation. 2014 Mar; 45(3):918-44. Epub 2014 Jan 23.
2014 Mar
Kelly AG, Zahuranec DB, Holloway RG, Morgenstern LB, Burke JF. "Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons." Stroke; a journal of cerebral circulation. 2014 Mar; 45(3):822-7. Epub 2014 Feb 12.
2014 Feb
Kelly AG, Sahin B, Holloway RG. "Ethical considerations in stroke patients." Current opinion in neurology. 2014 Feb; 27(1):61-5.
2014
Wilson R, Kieburtz K, Holloway RG, Kim SY. "Evidence-based research ethics and determinations of "engagement in research"." IRB. 2014 36(2):10-3.
2013 Oct
Young KC, Kelly AG, Holloway RG. "Reading a cost-effectiveness or decision analysis study: Five things to consider." Neurology. Clinical practice. 2013 Oct; 3(5):413-420.
2013 Sep 25
Sollenberger JF, Holloway RG. "The evolving role and value of libraries and librarians in health care." JAMA. 2013 Sep 25; 310(12):1231-2.
2013 Feb 19
Holloway RG, Gramling R, Kelly AG. "Estimating and communicating prognosis in advanced neurologic disease." Neurology. 2013 Feb 19; 80(8):764-72.
2013 Feb
Benesch CG, Holloway RG. "Too important to fail." Annals of neurology. 2013 Feb; 73(2):153-4.
2013
Kim SY, de Vries R, Wilson R, Parnami S, Frank S, Kieburtz K, Holloway RG. "Research participants' "irrational" expectations: common or commonly mismeasured?" IRB. 2013 35(1):1-9.
2012 Sep 15
Kim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K. "Sham surgery controls in Parkinson's disease clinical trials: views of participants." Movement disorders : official journal of the Movement Disorder Society. 2012 Sep 15; 27(11):1461-5. Epub 2012 Aug 23.
2012 Sep 15
Weaver FM, Stroupe KT, Cao L, Holloway RG, Vickrey BG, Simuni T, Hendricks A, Ippolito D. "Parkinson's disease medication use and costs following deep brain stimulation." Movement disorders : official journal of the Movement Disorder Society. 2012 Sep 15; 27(11):1398-403. Epub 2012 Sep 13.
2012 Aug 28
Kelly AG, Hoskins KD, Holloway RG. "Early stroke mortality, patient preferences, and the withdrawal of care bias." Neurology. 2012 Aug 28; 79(9):941-4.
2012 Jul
Creutzfeldt CJ, Holloway RG, Walker M. "Symptomatic and palliative care for stroke survivors." Journal of general internal medicine. 2012 Jul; 27(7):853-60. Epub 2012 Jan 19.
2012 Jun
Xian Y, Holloway RG, Pan W, Peterson ED. "Challenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates." Stroke; a journal of cerebral circulation. 2012 Jun; 43(6):1687-90. Epub 2012 Apr 24.
2012 May 3
Quill TE, Holloway RG. "Evidence, preferences, recommendations--finding the right balance in patient care." The New England journal of medicine. 2012 May 3; 366(18):1653-5.
2012 Apr
Kim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K. "Comparison of enrollees and decliners of Parkinson disease sham surgery trials." Movement disorders : official journal of the Movement Disorder Society. 2012 Apr; 27(4):506-11. Epub 2012 Feb 07.
2012
Creutzfeldt CJ, Holloway RG. "Treatment decisions after severe stroke: uncertainty and biases." Stroke; a journal of cerebral circulation. 2012 43(12):3405-8. Epub 2012 Nov 13.
2011 Jul 26
Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW. "Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study." Neurology. 2011 Jul 26; 77(4):355-63. Epub 2011 Jul 20.
2011 Jun
Holloway RG, Ringel SP. "Getting to value in neurological care: a roadmap for academic neurology." Annals of neurology. 2011 Jun; 69(6):909-18.
2011 Feb 22
Hyland MH, Holloway RG. "Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA." Neurology. 2011 Feb 22; 76(8):e31-3.
2011 Feb 1
Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B. "Racial differences in mortality among patients with acute ischemic stroke: an observational study." Annals of internal medicine. 2011 Feb 1; 154(3):152-9.
2011 Jan 26
Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B. "Association between stroke center hospitalization for acute ischemic stroke and mortality." JAMA. 2011 Jan 26; 305(4):373-80.
2011
Olden,A. M.; Holloway,R.; Ladwig,S.; Quill,T. E.; van Wijngaarden,E.;. "Palliative Care Needs and Symptom Patterns of Hospitalized Elders Referred for Consultation". J.Pain Symptom Manage. 2011; .
2011
Xian,Y.; Holloway,R. G.; Chan,P. S.; Noyes,K.; Shah,M. N.; Ting,H. H.; Chappel,A. R.; Peterson,E. D.; Friedman,B.;. "Association between stroke center hospitalization for acute ischemic stroke and mortality". JAMA. 2011; 305(4): 373-380.
2011
Xian,Y.; Holloway,R. G.; Noyes,K.; Shah,M. N.; Friedman,B.;. "Racial differences in mortality among patients with acute ischemic stroke: an observational study". Ann.Intern.Med. 2011; 154(3): 152-159.
2011
Holloway RG. "In lieu of flowers…." Journal of palliative medicine. 2011 14(12):1348-9.
2010 Aug 24
Kelly AG, Holloway RG. "Health state preferences and decision-making after malignant middle cerebral artery infarctions." Neurology. 2010 Aug 24; 75(8):682-7. Epub 2010 Jul 14.
2010 Jul 13
Kim SY, Holloway RG. "Is it research?: an increasingly common question." Neurology. 2010 Jul 13; 75(2):102-4.
2010 May 13
Holloway RG, Quill TE. "Treatment decisions after brain injury--tensions among quality, preference, and cost." The New England journal of medicine. 2010 May 13; 362(19):1757-9.
2010 Apr
Holloway RG, Ladwig S, Robb J, Kelly A, Nielsen E, Quill TE. "Palliative care consultations in hospitalized stroke patients." Journal of palliative medicine. 2010 Apr; 13(4):407-12.
2010 Feb
Xian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC, . "Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals." American heart journal. 2010 Feb; 159(2):207-14.
2010
Holloway,R. G.; Ladwig,S.; Robb,J.; Kelly,A.; Nielsen,E.; Quill,T. E.;. "Palliative care consultations in hospitalized stroke patients". J.Palliat.Med. 2010; 13(4): 407-412.
2010
Holloway,R. G.; Quill,T. E.;. "Treatment decisions after brain injury--tensions among quality, preference, and cost". N.Engl.J.Med. 2010; 362(19): 1757-1759.
2010
Kelly,A. G.; Holloway,R. G.;. "Health state preferences and decision-making after malignant middle cerebral artery infarctions". Neurology. 2010; 75(8): 682-687.
2010
Kim,S. Y.; Holloway,R. G.;. "Is it research?: an increasingly common question". Neurology. 2010; 75(2): 102-104.
2010
Olden,A. M.; Holloway,R.;. "Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis". J.Palliat.Med. 2010; 13(1): 59-65.
2010
Xian,Y.; Pan,W.; Peterson,E. D.; Heidenreich,P. A.; Cannon,C. P.; Hernandez,A. F.; Friedman,B.; Holloway,R. G.; Fonarow,G. C.; GWTG Steering Committee and Hospitals;. "Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals". Am.Heart J. 2010; 159(2): 207-214.
2010
Young,K. C.; Holloway,R. G.; Burgin,W. S.; Benesch,C. G.;. "A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy". J.Stroke Cerebrovasc Dis. 2010; 19(5): 404-409.
2010
Young KC, Holloway RG, Burgin WS, Benesch CG. "A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2010 19(5):404-9.
2009 Oct 15
Pogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP. "Patient and organizational factors related to education and support use by Veterans with Parkinson's disease." Movement disorders : official journal of the Movement Disorder Society. 2009 Oct 15; 24(13):1916-24.
2009 Sep
Yurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M. "Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model." Journal of women's health. 2009 Sep; 18(9):1355-60.
2009 Jul 21
Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG. "Selegiline shortage: Causes and costs of a generic drug shortage." Neurology. 2009 Jul 21; 73(3):213-7.
2009 Jul
Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR, , . "A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association." Stroke; a journal of cerebral circulation. 2009 Jul; 40(7):2616-34. Epub 2009 May 07.
2009 Apr 15
Dorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H. "Funding of Parkinson research from industry and US federal and foundation sources." Movement disorders : official journal of the Movement Disorder Society. 2009 Apr 15; 24(5):731-7.
2009 Feb
Holloway RG, Benesch C. "When disclosures are more interesting than the evidence." Stroke; a journal of cerebral circulation. 2009 Feb; 40(2):e44; author reply e45. Epub 2008 Dec 18.
2009
Dorsey,E. R.; Thompson,J. P.; Carrasco,M.; de Roulet,J.; Vitticore,P.; Nicholson,S.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;. "Financing of U.S. biomedical research and new drug approvals across therapeutic areas". PLoS One. 2009; 4(9): e7015.
2009
Dorsey,E. R.; Thompson,J. P.; Frasier,M.; Sherer,T.; Fiske,B.; Nicholson,S.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;. "Funding of Parkinson research from industry and US federal and foundation sources". Mov.Disord. 2009; 24(5): 731-737.
2009
Friedman,D.; Feldon,S.; Holloway,R.; Fisher,S.;. "Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department". Headache. 2009; 49(8): 1163-1173.
2009
Holloway,R. G.; Benesch,C.;. "When disclosures are more interesting than the evidence". Stroke. 2009; 40(2): e44; author reply e45.
2009
Kim,S. Y.; Schrock,L.; Wilson,R. M.; Frank,S. A.; Holloway,R. G.; Kieburtz,K.; de Vries,R. G.;. "An approach to evaluating the therapeutic misconception". IRB. 2009; 31(5): 7-14.
2009
Pogoda,T. K.; Cramer,I. E.; Meterko,M.; Lin,H.; Hendricks,A.; Holloway,R. G.; Charns,M. P.;. "Patient and organizational factors related to education and support use by Veterans with Parkinson's disease". Mov.Disord. 2009; 24(13): 1916-1924.
2009
Schwamm,L. H.; Holloway,R. G.; Amarenco,P.; Audebert,H. J.; Bakas,T.; Chumbler,N. R.; Handschu,R.; Jauch,E. C.; Knight,W. A.,4th; Levine,S. R.; Mayberg,M.; Meyer,B. C.; Meyers,P. M.; Skalabrin,E.; Wechsler,L. R.; American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease;. "A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association". Stroke. 2009; 40(7): 2616-2634.
2009
Yurcheshen,M. E.; Guttuso,T.,Jr; McDermott,M.; Holloway,R. G.; Perlis,M.;. "Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model". J.Womens Health.(Larchmt). 2009; 18(9): 1355-1360.
2009
Dorsey ER, Thompson JP, Carrasco M, de Roulet J, Vitticore P, Nicholson S, Johnston SC, Holloway RG, Moses H. "Financing of U.S. biomedical research and new drug approvals across therapeutic areas." PloS one. 2009 4(9):e7015. Epub 2009 Sep 11.
2009
Kim SY, Schrock L, Wilson RM, Frank SA, Holloway RG, Kieburtz K, de Vries RG. "An approach to evaluating the therapeutic misconception." IRB. 2009 31(5):7-14.
2008 Jul 29
Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. "Quantitative risk-benefit analysis of natalizumab." Neurology. 2008 Jul 29; 71(5):357-64.
2008 Jul 1
Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO. "Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines." Neurology. 2008 Jul 1; 71(1):57-63.
2008 Apr 29
Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC. "Invited article: Neurology and quality improvement: an introduction." Neurology. 2008 Apr 29; 70(18):1636-40.
2008 Jan
Frank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY. "Ethics of sham surgery: perspective of patients." Movement disorders : official journal of the Movement Disorder Society. 2008 Jan; 23(1):63-8.
2008
Frank,S. A.; Wilson,R.; Holloway,R. G.; Zimmerman,C.; Peterson,D. R.; Kieburtz,K.; Kim,S. Y.;. "Ethics of sham surgery: perspective of patients". Mov.Disord. 2008; 23(1): 63-68.
2008
Goetz,C. G.; Tilley,B. C.; Shaftman,S. R.; Stebbins,G. T.; Fahn,S.; Martinez-Martin,P.; Poewe,W.; Sampaio,C.; Stern,M. B.; Dodel,R.; Dubois,B.; Holloway,R.; Jankovic,J.; Kulisevsky,J.; Lang,A. E.; Lees,A.; Leurgans,S.; LeWitt,P. A.; Nyenhuis,D.; Olanow,C. W.; Rascol,O.; Schrag,A.; Teresi,J. A.; van Hilten,J. J.; LaPelle,N.; Movement Disorder Society UPDRS Revision Task Force;. "Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results". Mov.Disord. 2008; 23(15): 2129-2170.
2008
Kelly,A.; Thompson,J. P.; Tuttle,D.; Benesch,C.; Holloway,R. G.;. "Public reporting of quality data for stroke: is it measuring quality?". Stroke. 2008; 39(12): 3367-3371.
2008
Kim,S. Y.; Holloway,R. G.; Frank,S.; Wilson,R.; Kieburtz,K.;. "Trust in early phase research: therapeutic optimism and protective pessimism". Med.Health Care Philos. 2008; 11(4): 393-401.
2008
O'Connor,A. B.; Noyes,K.; Holloway,R. G.;. "A cost-utility comparison of four first-line medications in painful diabetic neuropathy". Pharmacoeconomics. 2008; 26(12): 1045-1064.
2008
Kim SY, Holloway RG, Frank S, Wilson R, Kieburtz K. "Trust in early phase research: therapeutic optimism and protective pessimism." Medicine, health care, and philosophy. 2008 11(4):393-401. Epub 2008 Jul 16.
2008
Kelly A, Thompson JP, Tuttle D, Benesch C, Holloway RG. "Public reporting of quality data for stroke: is it measuring quality?" Stroke; a journal of cerebral circulation. 2008 39(12):3367-71. Epub 2008 Sep 04.
2008
O'Connor AB, Noyes K, Holloway RG. "A cost-utility comparison of four first-line medications in painful diabetic neuropathy." PharmacoEconomics. 2008 26(12):1045-64.
2007 Oct
Dorsey ER, Holloway RG. "Quality of life in epilepsy, multiple sclerosis, and beyond." Annals of neurology. 2007 Oct; 62(4):307-8.
2007 Aug 15
Holloway RG, Quill TE. "Mortality as a measure of quality: implications for palliative and end-of-life care." JAMA. 2007 Aug 15; 298(7):802-4.
2007 Aug
O'Connor AB, Noyes K, Holloway RG. "A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia." Journal of the American Geriatrics Society. 2007 Aug; 55(8):1176-84.
2007 Jul 10
Biglan KM, Holloway RG, McDermott MP, Richard IH, . "Risk factors for somnolence, edema, and hallucinations in early Parkinson disease." Neurology. 2007 Jul 10; 69(2):187-95.
2007 Jun
Norton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE. "Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients." Critical care medicine. 2007 Jun; 35(6):1530-5.
2007 May 1
Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR. "Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis." Neurology. 2007 May 1; 68(18):1524-8.
2007 Apr 17
Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S. "Health care costs decline after successful epilepsy surgery." Neurology. 2007 Apr 17; 68(16):1290-8.
2007 Mar 15
Noyes K, Liu H, Holloway R, Dick AW. "Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey." Movement disorders : official journal of the Movement Disorder Society. 2007 Mar 15; 22(4):509-14.
2007 Feb 20
Rizzo M, Glick TH. "Medical errors after stroke: preventable or inevitable?" Neurology. 2007 Feb 20; 68(8):542-3.
2007 Feb 20
Holloway RG, Tuttle D, Baird T, Skelton WK. "The safety of hospital stroke care." Neurology. 2007 Feb 20; 68(8):550-5.
2007 Jan 30
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. "Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030." Neurology. 2007 Jan 30; 68(5):384-6. Epub 2006 Nov 02.
2007 Jan 2
Little DM, Holloway RG. "Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?" Neurology. 2007 Jan 2; 68(1):9-10.
2007 Jan
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. "Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan." Movement disorders : official journal of the Movement Disorder Society. 2007 Jan; 22(1):41-7.
2007
Biglan,K. M.; Holloway,R. G.,Jr; McDermott,M. P.; Richard,I. H.; Parkinson Study Group CALM-PD Investigators;. "Risk factors for somnolence, edema, and hallucinations in early Parkinson disease". Neurology. 2007; 69(2): 187-195.
2007
Dorsey,E. R.; Holloway,R. G.;. "Quality of life in epilepsy, multiple sclerosis, and beyond". Ann.Neurol. 2007; 62(4): 307-308.
2007
Goetz,C. G.; Fahn,S.; Martinez-Martin,P.; Poewe,W.; Sampaio,C.; Stebbins,G. T.; Stern,M. B.; Tilley,B. C.; Dodel,R.; Dubois,B.; Holloway,R.; Jankovic,J.; Kulisevsky,J.; Lang,A. E.; Lees,A.; Leurgans,S.; LeWitt,P. A.; Nyenhuis,D.; Olanow,C. W.; Rascol,O.; Schrag,A.; Teresi,J. A.; Van Hilten,J. J.; LaPelle,N.;. "Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan". Mov.Disord. 2007; 22(1): 41-47.
2007
Holloway,R. G.; Quill,T. E.;. "Mortality as a measure of quality: implications for palliative and end-of-life care". JAMA. 2007; 298(7): 802-804.
2007
Holloway,R. G.; Tuttle,D.; Baird,T.; Skelton,W. K.;. "The safety of hospital stroke care". Neurology. 2007; 68(8): 550-555.
2007
Little,D. M.; Holloway,R. G.;. "Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?". Neurology. 2007; 68(1): 9-10.
2007
Norton,S. A.; Hogan,L. A.; Holloway,R. G.; Temkin-Greener,H.; Buckley,M. J.; Quill,T. E.;. "Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients". Crit.Care Med. 2007; 35(6): 1530-1535.
2007
Noyes,K.; Dick,A. W.; Holloway,R. G.;. "The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation". Med.Decis.Making. 2007; 27(3): 327-334.
2007
Noyes,K.; Liu,H.; Holloway,R.; Dick,A. W.;. "Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey". Mov.Disord. 2007; 22(4): 509-514.
2007
O'Connor,A. B.; Noyes,K.; Holloway,R. G.;. "A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia". J.Am.Geriatr.Soc. 2007; 55(8): 1176-1184.
2007
Noyes K, Dick AW, Holloway RG. "The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation." Medical decision making : an international journal of the Society for Medical Decision Making. 2007 27(3):327-34. Epub 2007 May 14.
2006 Sep 12
Johnston KC, Holloway RG. "There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies." Neurology. 2006 Sep 12; 67(5):740-1.
2006 Jun
Dorsey ER, Holloway RG, Ravina BM. "Biomarkers in Parkinson's disease." Expert review of neurotherapeutics. 2006 Jun; 6(6):823-31.
2006 Apr 11
Kim SY, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K. "Volunteering for early phase gene transfer research in Parkinson disease." Neurology. 2006 Apr 11; 66(7):1010-5. Epub 2006 Mar 15.
2006 Mar 28
Noyes K, Liu H, Holloway RG. "What is the risk of developing parkinsonism following neuroleptic use?" Neurology. 2006 Mar 28; 66(6):941-3.
2006 Mar 21
Holloway RG, Józefowicz RF. "Update in neurology." Annals of internal medicine. 2006 Mar 21; 144(6):421-6.
2006 Mar
Noyes K, Liu H, Li Y, Holloway R, Dick AW. "Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries." Movement disorders : official journal of the Movement Disorder Society. 2006 Mar; 21(3):362-72.
2006
Dorsey,E. R.; Holloway,R. G.; Ravina,B. M.;. "Biomarkers in Parkinson's disease". Expert Rev.Neurother. 2006; 6(6): 823-831.
2006
Dorsey,E. R.; Vitticore,P.; De Roulet,J.; Thompson,J. P.; Carrasco,M.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;. "Financial anatomy of neuroscience research". Ann.Neurol. 2006; 60(6): 652-659.
2006
Henry,J. C.; Holloway,R.;. "Review: lorazepam provides the best control for status epilepticus". Evid Based.Med. 2006; 11(2): 54.
2006
Henry,J. C.; Holloway,R.;. "Review: Lorazepam provides the best control for status epilepticus". ACP J.Club. 2006; 144(2): 35.
2006
Holloway,R. G.,Jr; Jozefowicz,R. F.;. "Update in neurology". Ann.Intern.Med. 2006; 144(6): 421-426.
2006
Johnston,K. C.; Holloway,R. G.;. "There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies". Neurology. 2006; 67(5): 740-741.
2006
Kelly,A. G.; Holloway,R. G.;. "Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients". ACP J.Club. 2006; 145(3): 77.
2006
Noyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;. "Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life". Value Health. 2006; 9(1): 28-38.
2006
Noyes,K.; Liu,H.; Holloway,R. G.;. "What is the risk of developing parkinsonism following neuroleptic use?". Neurology. 2006; 66(6): 941-943.
2006
Noyes,K.; Liu,H.; Li,Y.; Holloway,R.; Dick,A. W.;. "Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries". Mov.Disord. 2006; 21(3): 362-372.
2006
Noyes K, Dick AW, Holloway RG, . "Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2006 9(1):28-38.
2006
Kelly AG, Holloway RG. "Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients." ACP journal club. 2006 145(3):77.
2006
Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H. "Financial anatomy of neuroscience research." Annals of neurology. 2006 60(6):652-9.
2005 Oct 11
Frank S, Kieburtz K, Holloway R, Kim SY. "What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports." Neurology. 2005 Oct 11; 65(7):1101-3. Epub 2005 Jul 20.
2005 Sep 27
Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J, . "Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology." Neurology. 2005 Sep 27; 65(6):794-801.
2005 Sep
Kim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K. "Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers." Archives of neurology. 2005 Sep; 62(9):1357-60.
2005 Aug 10
Holloway RG, Benesch CG, Burgin WS, Zentner JB. "Prognosis and decision making in severe stroke." JAMA. 2005 Aug 10; 294(6):725-33.
2005 Jun
Williams LS, Holloway RG. "How much is a good night's sleep worth?" Stroke; a journal of cerebral circulation. 2005 Jun; 36(6):1293-4.
2005 Mar
Guttuso T, Vitticore P, Holloway RG. "Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report." Journal of neurosurgery. 2005 Mar; 102(3):547-9.
2005 Feb 1
Lindsay MP, Kapral MK, Gladstone D, Holloway R, Tu JV, Laupacis A, Grimshaw JM. "The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2005 Feb 1; 172(3):363-5.
2005 Jan 25
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. "The role of radiotracer imaging in Parkinson disease." Neurology. 2005 Jan 25; 64(2):208-15.
2005 Jan 11
Holloway RG. "Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society." Neurology. 2005 Jan 11; 64(1):172-4; author reply 172-4.
2005
Frank,S.; Kieburtz,K.; Holloway,R.; Kim,S. Y.;. "What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports". Neurology. 2005; 65(7): 1101-1103.
2005
Guttuso,T.,Jr; Vitticore,P.; Holloway,R. G.;. "Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report". J.Neurosurg. 2005; 102(3): 547-549.
2005
Holloway,R.;. "The Babinski sign: thumbs up or toes down?". Neurology. 2005; 65(8): 1147.
2005
Holloway,R.;. "Timing and route of enteral tube-feeding did not reduce death or poor outcome in stroke and dysphagia". ACP J.Club. 2005; 143(2): 37.
2005
Holloway,R.;. "Protein-energy supplementation of normal hospital diet did not improve outcomes after recent stroke". ACP J.Club. 2005; 143(2): 36.
2005
Holloway,R. G.;. "Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society". Neurology. 2005; 64(1): 172-4; author reply 172-4.
2005
Holloway,R. G.; Benesch,C. G.; Burgin,W. S.; Zentner,J. B.;. "Prognosis and decision making in severe stroke". JAMA. 2005; 294(6): 725-733.
2005
Kim,S. Y.; Frank,S.; Holloway,R.; Zimmerman,C.; Wilson,R.; Kieburtz,K.;. "Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers". Arch.Neurol. 2005; 62(9): 1357-1360.
2005
Lindsay,M. P.; Kapral,M. K.; Gladstone,D.; Holloway,R.; Tu,J. V.; Laupacis,A.; Grimshaw,J. M.;. "The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care". CMAJ. 2005; 172(3): 363-365.
2005
Noyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;. "Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness". Pharmacoeconomics. 2005; 23(12): 1257-1270.
2005
Williams,L. S.; Holloway,R. G.;. "How much is a good night's sleep worth?". Stroke. 2005; 36(6): 1293-1294.
2005
Noyes K, Dick AW, Holloway RG, . "Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness." PharmacoEconomics. 2005 23(12):1257-70.
2004 Sep
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, . "Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations." Movement disorders : official journal of the Movement Disorder Society. 2004 Sep; 19(9):1020-8.
2004 Aug 24
. "Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis." Neurology. 2004 Aug 24; 63(4):718-20.
2004 Aug
Holloway R, Nesbit K, Bordley D, Noyes K. "Teaching and evaluating first and second year medical students' practice of evidence-based medicine." Medical education. 2004 Aug; 38(8):868-78.
2004 Aug
Tuttle D, Holloway R, Baird T, Sheehan B, Skelton WK. "Electronic reporting to improve patient safety." Quality & safety in health care. 2004 Aug; 13(4):281-6.
2004 Jul
Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A, . "Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial." Archives of neurology. 2004 Jul; 61(7):1044-53.
2004 Jul
Holloway RG, Siderowf AD. "Evidence-based neurotherapeutics: a spectrum of evidence." NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 2004 Jul; 1(3):295-7.
2004 Jul
Noyes K, Holloway RG. "Evidence from cost-effectiveness research." NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 2004 Jul; 1(3):348-55.
2004
Goetz,C. G.; Poewe,W.; Rascol,O.; Sampaio,C.; Stebbins,G. T.; Counsell,C.; Giladi,N.; Holloway,R. G.; Moore,C. G.; Wenning,G. K.; Yahr,M. D.; Seidl,L.; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease;. "Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations". Mov.Disord. 2004; 19(9): 1020-1028.
2004
Holloway,R.; Dick,A. W.;. "Editorial comment--stroke cost-effectiveness research: are acceptability curves acceptable?". Stroke. 2004; 35(1): 203-204.
2004
Holloway,R.; Frank,S.;. "Review: anticholinergic drugs improve motor function and disability in Parkinson disease". ACP J.Club. 2004; 140(1): 15.
2004
Holloway,R.; Nesbit,K.; Bordley,D.; Noyes,K.;. "Teaching and evaluating first and second year medical students' practice of evidence-based medicine". Med.Educ. 2004; 38(8): 868-878.
2004
Holloway,R. G.; Siderowf,A. D.;. "Evidence-based neurotherapeutics: a spectrum of evidence". NeuroRx. 2004; 1(3): 295-297.
2004
Noyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;. "Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial". Med.Decis.Making. 2004; 24(5): 472-485.
2004
Noyes,K.; Holloway,R. G.;. "Evidence from cost-effectiveness research". NeuroRx. 2004; 1(3): 348-355.
2004
Noyes K, Dick AW, Holloway RG, . "Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial." Medical decision making : an international journal of the Society for Medical Decision Making. 2004 24(5):472-85.
2003 Jul 22
Frank S, Holloway R. "Medical errors on an inpatient neurology service." Neurology. 2003 Jul 22; 61(2):254-7.
2003 Jul
Kim SY, Holloway RG. "Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis." The American journal of psychiatry. 2003 Jul; 160(7):1272-6.
2003 Jul
Biglan KM, Holloway RG. "Surrogate endpoints in Parkinson's disease research." Current neurology and neuroscience reports. 2003 Jul; 3(4):314-20.
2003 Jun
Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J, . "Development and testing of the Parkinson's disease quality of life scale." Movement disorders : official journal of the Movement Disorder Society. 2003 Jun; 18(6):637-45.
2003 Feb 11
Nodera H, Herrmann DN, Holloway RG, Logigian EL. "A Bayesian argument against rigid cut-offs in electrodiagnosis of median neuropathy at the wrist." Neurology. 2003 Feb 11; 60(3):458-64.
2003
Biglan,K. M.; Holloway,R. G.;. "Surrogate endpoints in Parkinson's disease research". Curr.Neurol.Neurosci.Rep. 2003; 3(4): 314-320.
2003
Frank,S.; Holloway,R.;. "Medical errors on an inpatient neurology service". Neurology. 2003; 61(2): 254-257.
2003
Kim,S. Y.; Holloway,R. G.;. "Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis". Am.J.Psychiatry. 2003; 160(7): 1272-1276.
2003
Welsh,M.; McDermott,M. P.; Holloway,R. G.; Plumb,S.; Pfeiffer,R.; Hubble,J.; Parkinson Study Group;. "Development and testing of the Parkinson's disease quality of life scale". Mov.Disord. 2003; 18(6): 637-645.
2002 Nov
Gottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM. "CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes." Radiology. 2002 Nov; 225(2):441-9.
2002 Apr 3
. "Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression." JAMA. 2002 Apr 3; 287(13):1653-61.
2002 Mar 12
Holloway RG, Dick AW. "Clinical trial end points: on the road to nowhere?" Neurology. 2002 Mar 12; 58(5):679-86.
2002 Feb
Biglan KM, Holloway RG. "A review of pramipexole and its clinical utility in Parkinson's disease." Expert opinion on pharmacotherapy. 2002 Feb; 3(2):197-210.
2002
Biglan,K. M.; Holloway,R. G.;. "A review of pramipexole and its clinical utility in Parkinson's disease". Expert Opin.Pharmacother. 2002; 3(2): 197-210.
2002
Gottlieb,R. H.; La,T. C.; Erturk,E. N.; Sotack,J. L.; Voci,S. L.; Holloway,R. G.; Syed,L.; Mikityansky,I.; Tirkes,A. T.; Elmarzouky,R.; Zwemer,F. L.; Joseph,J. V.; Davis,D.; DiGrazio,W. J.; Messing,E. M.;. "CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes". Radiology. 2002; 225(2): 441-449.
2002
Holloway,R. G.; Dick,A. W.;. "Clinical trial end points: on the road to nowhere?". Neurology. 2002; 58(5): 679-686.
2001 Nov 13
. "Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis." Neurology. 2001 Nov 13; 57(9):1566-70.
2001 Oct 23
Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R, . "Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy." Neurology. 2001 Oct 23; 57(8):1434-40.
2001 Sep
Holloway RG, Vickrey BG, Benesch C, Hinchey JA, Bieber J, . "Development of performance measures for acute ischemic stroke." Stroke; a journal of cerebral circulation. 2001 Sep; 32(9):2058-74.
2001 Aug 28
Tomaszewski KJ, Holloway RG. "Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis." Neurology. 2001 Aug 28; 57(4):663-71.
2001 Jul
Biglan K, Holloway RG. "Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials." Current neurology and neuroscience reports. 2001 Jul; 1(4):329-36.
2001 May 8
Pippenger M, Holloway RG, Vickrey BG. "Neurologists' use of ICD-9CM codes for dementia." Neurology. 2001 May 8; 56(9):1206-9.
2001 Apr 24
Holloway RG, Panzer RJ. "Lawyers, litigation, and liability: can they make patients safer?" Neurology. 2001 Apr 24; 56(8):991-3.
2000 Nov 28
Holloway RG, Ringel SP, Bernat JL, Keran CM, Lawyer BL. "US neurologists: attitudes on rationing." Neurology. 2000 Nov 28; 55(10):1492-7.
2000 Nov 28
"A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group." Neurology. 2000 Nov 28; 55(10):1540-7.
2000 Oct 18
. "Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group." JAMA. 2000 Oct 18; 284(15):1931-8.
2000 Oct 9
Gifford DR, Holloway RG, Vickrey BG. "Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia." Archives of internal medicine. 2000 Oct 9; 160(18):2855-62.
2000 May 23
Holloway RG, Benesch C, Rush SR. "Stroke prevention: narrowing the evidence-practice gap." Neurology. 2000 May 23; 54(10):1899-906.
2000 May
Siderowf AD, Holloway RG, Stern MB. "Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions." Movement disorders : official journal of the Movement Disorder Society. 2000 May; 15(3):439-45.
2000 Apr 25
Zivin JA, Holloway RG. "Weighing the evidence on DWI: caveat emptor." Neurology. 2000 Apr 25; 54(8):1552.
2000 Jan 11
Larson WL, Holloway RG, Keran CM. "Employment-seeking experiences of residents in 1996: a window into the neurology marketplace." Neurology. 2000 Jan 11; 54(1):214-8.
2000
"A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group." Clinical neuropharmacology. 2000 23(1):34-44.
2000
Holloway RG, Kantrowitz JT, St James EC, Giang D, Schwarz K. "Resolution of transient ischemic attacks and aortic arch thrombi on anticoagulant therapy." European neurology. 2000 43(3):184-5.
1999 Sep 10
Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. "Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team." AIDS. 1999 Sep 10; 13(13):1677-85.
1999 Aug 17
Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG. "Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial." Annals of internal medicine. 1999 Aug 17; 131(4):237-46.
1999 Aug
Holloway RG, Gifford DR, Frankel MR, Vickrey BG. "A randomized trial to implement practice recommendations: design and methods of the Dementia Care Study." Controlled clinical trials. 1999 Aug; 20(4):369-85.
1999 Jul
Holloway RG, Benesch CG, Rahilly CR, Courtright CE. "A systematic review of cost-effectiveness research of stroke evaluation and treatment." Stroke; a journal of cerebral circulation. 1999 Jul; 30(7):1340-9.
1999 Apr 22
Holloway RG, Vickrey BG, Keran CM, Lesser E, Iverson D, Larson W, Swarztrauber K. "US neurologists in the 1990's: trends in practice characteristics." Neurology. 1999 Apr 22; 52(7):1353-61.
1999
Holloway RG, Feasby TE. "To test or not to test? That is the question." Neurology. 1999 53(9):1905-7.
1999
Ebrahim S, Holloway RG, Benesch CG. "Systematic review of cost-effectiveness research of stroke evaluation and treatment" Stroke; a journal of cerebral circulation. 1999 30(12):2759-68.
1999
Schifitto G, Holloway R. "Cerebrovascular disease in patients with HIV-1 associated pulmonary hypertension." Journal of neuro-AIDS. 1999 2(2):57-64.
1998 Nov
Hoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG. "Cost effectiveness of pramipexole in Parkinson's disease in the US." PharmacoEconomics. 1998 Nov; 14(5):541-57.
1998 Aug
Holloway RG, Courtright CE, Rahilly CR, Totterman SM, Shrier D. "Magnetic resonance imaging in delayed brachial plexopathy following a clavicular fracture." European neurology. 1998 Aug; 40(2):105-6.
1998 Feb
Holloway RG, Ringel SP. "Narrowing the evidence-practice gap. Strengthening the link between research and clinical practice." Neurology. 1998 Feb; 50(2):319-21.
1998 Jan
Holloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP. "Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995." Archives of neurology. 1998 Jan; 55(1):25-32.
1998
Benesch,C.; Holloway RG;. "Economic impact of stoke and implications for interventions". CNS Drugs. 1998; 9(1): 29-39. Link
1998
Uchino A, Numaguchi Y, Holloway RG, Cherian N. "Reversible symptomatic venous congestion after treatment of dural arteriovenous fistula using NBCA." Radiation medicine. 1998 16(6):477-81.
1997
Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. "The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms." International journal of technology assessment in health care. 1997 13(1):21-34.
1996 Jun
Holloway RG. "Cost-effectiveness analysis: what is it and how will it influence neurology." Annals of neurology. 1996 Jun; 39(6):818-23.
1996 Apr
Holloway RG, Mushlin AI. "Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy." Neurology. 1996 Apr; 46(4):1010-5.
1996 Mar
Holloway RG, Witter DM, Lawton KB, Lipscomb J, Samsa G. "Inpatient costs of specific cerebrovascular events at five academic medical centers." Neurology. 1996 Mar; 46(3):854-60.
1996 Feb
Kieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED. "Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection." Archives of neurology. 1996 Feb; 53(2):155-8.
1995 May
Holloway RG, Kieburtz KD. "Headache and the human immunodeficiency virus type 1 infection." Headache. 1995 May; 35(5):245-55.
1989 May 15
Kiss I, Deák F, Holloway RG, Delius H, Mebust KA, Frimberger E, Argraves WS, Tsonis PA, Winterbottom N, Goetinck PF. "Structure of the gene for cartilage matrix protein, a modular protein of the extracellular matrix. Exon/intron organization, unusual splice sites, and relation to alpha chains of beta 2 integrins, von Willebrand factor, complement factors B and C2, and epidermal growth factor." The Journal of biological chemistry. 1989 May 15; 264(14):8126-34.
1976 Oct 16
Holloway RG. "Management can reverse declining employee work attitudeoblem solving." Hospitals. 1976 Oct 16; 50(20):71-77.
1976 May 16
Holloway RG. "Planning for results and specific outcomes." Hospitals. 1976 May 16; 50(10):77-8, 80, 82.
1976
Holloway RG. "The administrator and the future of collective actions." A report of the ... National Forum on Hospital and Health Affairs. 1976 :70-83.
1972 Aug 16
Holloway S, Holloway RG. "Work-study career mobility program." Hospitals. 1972 Aug 16; 46(16):73-6.
1968 Aug 16
Holloway RG, Lonergan WG. "A survey program for management and organizational development." Hospitals. 1968 Aug 16; 42(16):59-65.
1963
HOLLOWAY RG, ARTIS JW, FREEMAN WE. "The participation patterns of "economic influentials" and their control of a hospital board of trusties." Journal of health and human behavior. 1963 4:88-99.
0
Langfitt JL, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Vickrey, BG, Sperling MR, Spencer SS, Bazil CW, and Shinnar S. "Reduction in Health Care Costs After Successful Epilepsy Surgery: Results of a US Multi-center Study." Neurology. .
0
Noyes K, Dick AW, Holloway RG and the Parkinson Study Group. "Use of US-Specific EQ-5D Preference Weights: The Implications for the Cost-Effectiveness of Pramipexole." Medical Decision Making.
0
Biglan KM, Holloway RG, McDermott MP, Richard IR and the Parkinson Study Group CALM-PD Investigators. "Risk Factors for Somnolence, Edema and Hallucinations in Early Parkinson's Disease." Neurology. .
0
Norton SA, Hogan L, Holloway R, Temkin Greener H, Buckley M, and Quill TE. "Proactive Palliative Care in the Medical Intensive Care Unit: Reducing Length of Stay." Critical Care Medicine. .
0
O'Connor AB, K Noyes, Holloway RG. "A cost-effectiveness comparison of desirpramine, gabapentin, and pregabalin for treating postherpetic neuralgia." JAGS. .
0
Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. "A Clinical Decision Model of Two Disease Modifying Agents for Multiple Sclerosis." Intl. J. of Technology Assessment in Health Care.
0
Holloway RG, Quill TE. "Mortality as a measure of quality: implications for palliative and end-of-life care." JAMA. .

Books

2010
Holloway R.G., Quill T.E. "Palliative Care". Andreoli and Carpenter's Cecil Essentials of Medicine. T. E. Andreoli. Philadelphia: Elsevier, 2010. 1210-1217
2005
Noyes K and Holloway RG. "Economics of Parkinson's Disease". Parkinson's Disease. Ebadi M, Pfeiff. Boca Raton: CRC Press, 2005. 989-998
2004
Holloway RG, Vickrey BG, Thom DH.. "Evidence-based medicine". Neuroepidemiology: From Principles to Practice,. Nelson L, VanDen Eeden S, Tanner C, McGuire VM.. Oxford: Oxford University Press, 2004. 435-449
2004
Holloway RG, Vickrey BG. "Health Services Research in Neurology". Neuroepidemiology: From Principles to Practice. Nelson L, VanDen Eeden S, Tanner C, McGuire VM.. Oxford: Oxford University Press, 2004. 425-434
2003
Vickrey BG, Holloway RG.. "Evidence-based medicine". Neurological Therapeutics: Principles and Practice. Noseworthy J. Martin Dunitz Ltd.: London, UK., 2003. 49-54
2002
Holloway RG, Rush SR.. "Quality improvement in stroke prevention". The Prevention of Stroke. Gorelick PB, Alter M. New York: The Parthenon Publishing Group, 2002. 141-147
2000
Langfitt JT, Holloway RG:. "Economic prognosis: evaluating economic outcomes of health care.". Prognosis of Neurological Disorders. Evans, RW, Baskin, DS & Yatsu, FM. : Oxford University Press, New York, 2000. 57-70
2000
Blindauer KA, Benesch CG, Counihan T, Schwid SR, Toczek M, Wollman E, Holloway RG, Kieburtz K.. "Current Therapy". Baker's Clinical Neurology. Joynt RJ and RC Griggs. Philadelphia: Lippincott, Williams, and Wilkins Publishers, 2000.
2000
Siderowf A, Holloway RG.. "Economic impact of Parkinson's Disease: implications for interventions.". Parkinson's Disease Diagnosis and Clinical Management. Factor, SA, Weiner WJ. : Demos Medical Publishing, Inc., 2000. 639-645
1999
Jozefowicz RF, Holloway RG. Case Studies in Neuroscience. Philadelphia, PA: F.A. Davis Company, 1999.
1998
Holloway RG, Kieburtz K. "Neurologic Manifestations of HIV Infection". Principles and Practice of Infectious Diseases. Mandell, Bennett, and Dolin. New York, NY: W.B. Saunders Company, 1998. 1432-1439
1996
Goodman A, Benesch CG, Berg M, Calabresi PA, Dimitsopulos T, Holloway RG, Samuels O, Joynt RJ, Williams L, Wojcieszek J. "Current Therapy". Clinical Neurology. Joynt RJ and Griggs RC. Philadelphia, PA: JB Lippincott, 1996.
1996
Holloway RG, Kieburtz KD, Schiffito G. "HIV-1 infection and the nervous system". Clinical Neurology. Joynt RJ. Philadelphia, PA: JB Lippincott, 1996. 1-45
1995
Holloway RG, Kieburtz KD. "Headache associated with Acquired Immune Deficiency Syndrome". Neurobase. Davidoff DA. La Jolla, CA: Arbor Publishing Corp, 1995.
1995
Jozefowicz RF, Benesch CG, Berg M, Calabresi PA, Dimitsopulos T, Goodman A, Holloway RG, Joynt RJ, Williams L, Wojcieszek J. "Current Therapy". Clinical Neurology. Joynt RJ. Philadelphia, PA: JB Lippincott,, 1995. 1-35